Related Experiment Video
Updated: Aug 2, 2026
05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Dialysis-related amyloidosis.
1Department of Medicine, Northwestern University Medical School, Evanston Northwestern Healthcare, Evanston, IL 60201, USA.
Summary
Dialysis-related amyloidosis (DRA) stems from beta(2)-microglobulin modifications in long-term dialysis patients. Managing beta(2)M levels can improve symptoms and slow disease progression.
Area of Science:
- Nephrology
- Biochemistry
- Rheumatology
Background:
- Dialysis-related amyloidosis (DRA) is a significant complication in patients undergoing long-term dialysis.
- It arises from the accumulation of beta(2)-microglobulin (beta(2)M) amyloid fibrils in joints and surrounding tissues.
- This condition affects patients with chronic renal failure, including those on continuous ambulatory peritoneal dialysis.
Purpose of the Study:
- To review the chemical modifications of beta(2)M leading to amyloid fibril formation.
- To elucidate the pathogenesis of dialysis-related amyloidosis.
- To summarize the clinical manifestations, diagnosis, and treatment strategies for DRA.
Main Methods:
- Literature review focusing on the chemical changes in beta(2)M.
- Analysis of studies detailing the deposition of beta(2)amyloid fibrils.
- Compilation of clinical and radiographic findings associated with DRA.
Main Results:
- Chemical modifications of beta(2)M are central to the formation of beta(2)amyloid.
- Common clinical presentations include carpal tunnel syndrome, shoulder pain, and destructive arthropathy.
- Achieving normal serum beta(2)M levels in end-stage renal disease (ESRD) patients can lead to clinical improvement.
Conclusions:
- Understanding beta(2)M modifications is key to addressing DRA.
- Treatment aims to normalize beta(2)M levels, manage symptoms with corticosteroids or NSAIDs, and consider surgery for specific complications.
- Effective management can improve quality of life for affected patients.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:15Dialysis
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
01:27Dialysis
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...